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Evaluation of the Microscopic-Observation 
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Multidrug-Resistant Tuberculosis 
ABSTRACT 
New diagnostic tools are urgently needed to interrupt the transmission of tuberculosis and 
multidrug-resistant tuberculosis. The microscopic-observation drug-susceptibility (MODS) assay 
is a rapid, accurate and simple liquid culture method to detect multidrug-resistant tuberculosis 
(MDR-TB). MODS were evaluated to determine a lower and same concentration of isoniazid 
and rifampin for detection of MDR-TB. Direct drug-susceptibility testing was performed with 
the use of the MODS assay. Drug-sensitive control strains were tested daily. Drug-susceptibility 
testing was performed with the use of the proportion method using Mycobacteria Growth 
Indicator Tube (MGIT) medium. The drug concentrations that used for both isoniazid and 
rifampicin were at the same concentration: 0.16, 0.08 and 0.04 μg per milliliter. We tested 53 M. 
tuberculosis clinical isolates and 3 control strains M. tuberculosis H37RV. All concentration 
showed same result. Of 56 M. tuberculosis clinical isolates and control strains, 14 were MDR-
TB, 41 were susceptible with isoniazid and rifampicin, 1 was resistant with isoniazid but 
susceptible with rifampicin. A lower and same concentration of isoniazid and rifampicin can be 
used to detect MDR-TB using MODS method. Operational cost can be more efficient in 
resource-limited environments. However, additional studies evaluating the MODS in lower and 
same concentration of isoniazid and rifampin must be conducted with a larger number of clinical 
isolates. 
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INTRODUCTION 
There is an urgent need for low-cost methods for the diagnosis of Multidrug-resistant 
Tuberculosis (MDR-TB). MDR-TB threatens the success of global TB control. Detection of drug 
resistance is important, but widely used drug susceptibility tests on Lowenstein-Jensen slants or 
agar-containing plates are slow (1-4). Drug susceptibility tests performed by automated liquid 
culture systems are more rapid but expensive and therefore not widely used in resource-limited 
settings (2, 5). Therefore, an accurate, rapid, inexpensive and technically simple method for M. 
tuberculosis drug susceptibility testing is urgently needed priority for use in resource-poor 
settings and for areas with high rates of MDR TB.  
Microscopic-observation drug-susceptibility assay (MODS), a noncommercial TB culture 
and DST method, is recommended by World Health Organization (WHO) (6, 7). It is cheaper 
and has shorter turn-around time than conventional gold standard methods (8).  It has been 
validated in Peru and evaluated in some developing countries (9-14).  Several studies showed 
that MODS assay had 92%–97.5% sensitivity (5, 8, 13). MODS can detected drug resistance 
within 1–2 weeks even with low establishment cost and technical needs. It can be a reasonable 
solution for strengthening the TB diagnostic in developing countries (15). 
The MODS assay is a liquid culture method based on microscopic detection of 
characteristic M. tuberculosis morphology. The microscopic detection of mycobacterial by 
MODS is technically similar to microscopic examination of a smear. These are features that 
make MODS suitable for use in resource-poor settings (16). MODS assay uses enriched 
Middlebrook 7H-9 liquid medium and relies on microscopic detection of cording growth that is 
the characteristic of Mycobacterium tuberculosis. Potential advantages of the MODS assay are 
relatively rapid mycobacterial growth and reliance on microscopy skills similar to those used for 
smear microscopy (13). 
Given the challenges of the evaluation of techniques for the diagnosis of MDR-TB, our 
study was conducted to determine a lower and same concentration of isoniazid and rifampin for 
MDR-TB detection in more simple and cheaper application. 
 
 
 
MATERIAL AND METHODS 
Sample Collection 
A total of 56 M. tuberculosis clinical isolates were selected from the patients with 
suspected tuberculosis at the Infection Center of Wahidin Sudirohusodo Hospital, Makassar. The 
isoniazid-susceptible and rifampicin-susceptible strain M. tuberculosis H37Rv was used as 
controls in the susceptibility test for isoniazid and rifampin in lower concentrations.  
 
Detection of Mycobacterium tuberculosis  
Sputum samples were decontaminated according to the sodium hydroxide–N-acetyl-L-
cysteine method (17). An aliquot was used for microscopical examination of Ziehl-Neelsen 
stained sputum smears, and the remainder was used for parallel Lowenstein–Jensen culture, 
Mycobacteria Growth Indicator Tube (MGIT) culture, and MODS culture. Lowenstein–Jensen 
culture and MGIT culture were used as reference culture to confirm the detection of 
Mycobacterium tuberculosis. They were selected because they were reference methods 
commonly used in developing and industrialized countries, respectively. After inoculation of 5 μl 
of decontaminant specimen, Lowenstein–Jensen slants were incubated at 37°C and examined 
twice weekly from day 7 through day 60 (17). MGIT tubes were inoculated with 500 μl of 
decontaminant specimen, and cultures were monitored continuously every day after 2 days of 
inoculation using manual ultra violet machine. MGIT media were contain of middlebrook 7H9 , 
500 μl of oxalic acid, albumin, dextrose, and catalase (OADC) and 100 μl of polymyxin, 
amphotericin B, nalidixic acid, trimethoprim, and azlocillin (PANTA) antibiotics. Samples were 
negative culture if there were no Mycobacterium growth after monitored until 42 days. 
The MODS cultures were prepared in 24-well tissue-culture plates, each well containing 
720 μl of decontaminant specimen, Middlebrook 7H9 broth,  oxalic acid, albumin, dextrose, and 
catalase  (OADC),  and polymyxin,  amphotericin B, nalidixic acid,   trimethoprim, and azlocillin 
(PANTA). Antibiotic stock solutions were added to give the following final critical drug 
concentrations of INH and RIF: 0.16 μg/ml, 0.08 μg/ml and 0.04 μg/ml. The cultures were 
examined under an inverted light microscope at a magnification of 40× every day, from day 4 to 
day 15, on alternate days from day 16 to day 25, and twice weekly from day 26 to day 40. To 
minimize cross-contamination and occupational exposure, plates were permanently sealed inside 
plastic ziplock bags after inoculation and were subsequently examined within the bag. Positive 
cultures were identified by cord formation, characteristic of M. tuberculosis growth, in liquid 
medium in drug-free control wells, as described previously. Non-tuberculous mycobacteria were 
recognized by their lack of cording or, for M. chelonae (which is the only non-tuberculous 
mycobacteria that does form cords), by rapid overgrowth by day 5. Fungal or bacterial 
contamination was recognized by rapid over growth and clouding in wells. If contamination was 
detected, the original sample was cultured again after being decontaminated once more.  
 
 
Drug-susceptibility Testing 
Direct drug-susceptibility testing was performed with the use of the MODS assay, as previously 
described (12, 15). Growth in drug-free control wells but not in drug-containing wells indicated 
susceptibility. The drug concentrations that used for both isoniazid and rifampicin were at the 
same concentration: 0.16, 0.08 and 0.04 μg per milliliter. MGIT drug-susceptibility testing was 
performed as a reference. Drug-sensitive control strains were tested daily using MODS assay and 
MGIT. 
 
Statistical Analysis 
Data analysis was done by determining the growth of Mycobacterium tuberculosis using MODS 
assay for drug susceptibility test using the same and low concentration. Furthermore, all of the 
data were analyzed using IBM SPSS Statistical version 20 for the significances.   
 
 
 
 
 
 
 
 
 
 
RESULTS 
All of 56 M. tuberculosis clinical isolates and controls that have been cultured with MODS assay 
give identical results with reference method (LJ and MGIT) for the bacterial culture.(Table 1) 
From 56 M. tuberculosis clinical isolates and controls that have been tested with MODS assay 
using concentrations  0.16 μg/ml, 0.08 μg/ml and 0.04 μg/ml for both Isoniazid and Rifampin: 14 
were MDR-TB, 41 were susceptible with isoniazid and rifampicin, 1 was resistant with isoniazid 
but susceptible with rifampicin. (Table 1 and 2) Out of 56 M. tuberculosis clinical isolates that 
have been tested with MODS assay, 47 gave identical results with reference method for the three 
drugs concentration tested. (Table 3) 
Table1. Culture performance result of MODS Assay in reference to LJ and MGIT culture 
  MODS LJ MGIT 
  culture culture culture 
H37RV 
Positive Positive Positive n=3 
AFB + 
Positive Positive Positive n=53 
 
Table2. MODS Assay results obtained with lower concentration of Isoniazid 
Drug 
(conc) 
No. of isolates 
Susceptible MDR 
Susceptible Resistant 
with INH only with INH only 
0.04 μg/ml 38 14 0 1 
0.08 μg/ml 38 14 0 1 
0.16 μg/ml 38 14 0 1 
 
 
 
Table 3. MODS Assay results obtained with lower concentration of Rifampin 
     
Drug 
(conc) 
No. of isolates   
Susceptible MDR 
Susceptible Resistant 
with RIF only with RIF only 
0.04 
μg/ml 38 14 1 0 
0.08 
μg/ml 38 14 1 0 
0.16 
μg/ml 38 14 1 0 
 
 
 
Table 4. DST performance result of MODS Assay in reference to MGIT System 
susceptible MDR  INH resistant RIF resistant 
with MGIT with MGIT with MGIT with MGIT 
Susceptible with 
MODS 35 3 3 0 
MDR with MODS 1 12 1 0 
INH resistant with 
MODS 1 0 0 0 
RIF resistant with 
MODS 0 0 0 0 
 
 
 
DISCUSSION 
MODS assay provides low-cost, low technology culture method, safe (15) and more rapid time 
to positivity compared with the reference method for isoniazid and rifampin drug susceptibility 
testing with concurrent highly accurate identification of multidrug-resistant (MDR) strains in 
resource-limited settings with high tuberculosis Burden (16). Our study defines strengths of 
MODS assay in detecting MDR-TB and should enable the development of a streamlined for 
clinically useful method. There were no discrepancies results between MODS assay with both of 
references cultures methods. All of the M. tuberculosis clinical isolates and the control strains M. 
tuberculosis H37RV have positive results with MODS assay and both of the references culture 
methods. Detecting MDR-TB using MODS assay, previous studies were used drug concentration 
for isoniazid: 0.1μg/ml and 0.4μg/ml; rifampin: 1 μg/ml and 2 μg/ml. The uses of lower 
concentration for isoniazid and rifampin: 0.16 μg/ml, 0.08 μg/ml and 0.04 μg/ml in our study 
reduces the operational costs >100% but does not affect the performance of the MODS assay. 
There were no discrepancies among the result of the three concentrations that have been tested. 
By reducing the amount of the isoniazid and rifampin, we can detect a large number of MDR-TB 
samples. Using the same concentration for both of the antibiotics give us an easily workflow on 
antibiotic dilution which is more efficient and effective. In this case, any laboratory that has 
incubator, centrifuge, and microscope and is adequately biologically secured can safely perform 
MODS assay because all of the materials are available from major laboratory supplier. 
In conclusion, based on our results, MODS assay using lower and same concentration of 
isoniazid and rifampin can be performed to detect MDR-TB. Operational cost can be manage 
efficiently in resource-limited environments because of more simple and cheaper application of 
the MODS assay for drug susceptibility testing. However, additional studies evaluating the 
MODS assay using lower and same concentration of isoniazid and rifampin must be conducted 
with a larger number of clinical isolates and several more types of drugs. 
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